Advertisement

Topics

Cephalon GmbH Company Profile

16:29 EST 21st November 2017 | BioPortfolio

Für die Betreuung der Märkte in Deutschland, Österreich und der Schweiz wurde 1997 in München die Cephalon GmbH gegründet. Im Jahr 2002 erfolgte der Umzug nach Martinsried bei München, einem der Hauptzentren der deutschen Biotechnologie.

Location

Fraunhoferstr. 9a
Martinsried
D-82152
Germany

Contact

Phone: 49 89 895570-0
Fax: 49 89 895570-15
Email: info@cephalon.de


News Articles [133 Associated News Articles listed on BioPortfolio]

EU Accuses Teva and Cephalon of Antitrust Breach

The European Commission has accused Israeli drugmaker Teva and its US subsidiary Cephalon of breaching antitrust rules. Regulators classed an agreement between the companies to delay marketing of a ch...

Cephalon Purchase , PTV News: Feb 25, 2010

New data drives Cephalon to exercise option to buy Ception

Teva, Cephalon accused of pay-for-delay deal

European regulators believe that Teva and Cephalon breached antitrust rules with an agreement that effectively delayed the entry of generic competition to the latter’s blockbuster sleep disorder...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

European Commission (EC) Accuses Teva, Cephalon of Anti-Competitive Behavior

  Life Sciences Jobs   ...

04.26.12 -- Aptalis, Cephalon Win Federal Appeal For AMRIX Patents

04/26/12 Bioresearch Online Newsletter - Outsourced Pharma Edition

News Headlines, PTV News: Feb 25, 2010

Megablockbuster: Pfizer's Prevnar 13 approvedPay for Delay: US generics lawsuit dismissedAsthma asset: Cephalon pays US$ 250M for Ception

News Headlines , PTV News: Feb 24, 2010

Joining forces: Pharmagiants team up to fight cancer in AsiaFighting fungus: Astellas in US$ 500M deal with BasileaAsthma asset: Cephalon pays US$ 250M for Ception

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Cyclic and Torsional Fatigue Resistance of Reciprocating Single Files Manufactured by Different Nickel-titanium Alloys.

The aim of this study was to evaluate the cyclic and torsional fatigue resistance of the following reciprocating single-file systems: ProDesign R 25.06 (Easy Equipamentos Odontológicos, Belo Horizont...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [44 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg

The objective of this study was to investigate the bioequivalence of Mylan modafinil 200 mg tablets to Cephalon Provigil® 200 mg tablets following a single, oral 200 mg (1 x 200 mg) dose ...

Substudy to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

The substudy is a multicenter, open-label study consisting of a subset of the patients in Cephalon study C18083/3064/NL/MN who are receiving the investigational treatment (BR), for the pur...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Companies [532 Associated Companies listed on BioPortfolio]

Cephalon GmbH

Für die Betreuung der Märkte in Deutschland, Österreich und der Schweiz wurde 1997 in München die Cephalon GmbH gegründet. Im Jahr 2002 erfolgte der Umzug nach Martinsried bei München, einem der...

Cephalon

Cephalon seeks to discover, develop and market innovative products to treat neurological and sleep disorders, cancer, and pain. The company is committed to providing patients and the medical community...

Cephalon, Inc.

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

More Information about "Cephalon GmbH" on BioPortfolio

We have published hundreds of Cephalon GmbH news stories on BioPortfolio along with dozens of Cephalon GmbH Clinical Trials and PubMed Articles about Cephalon GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cephalon GmbH Companies in our database. You can also find out about relevant Cephalon GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record